Single Inhaler Extrafine Triple Therapy Improves Clinical Outcomes in Gold B COPD Patients: Post-Hoc Analysis of the TRIBUTE study

Pneumologie 2019; 73(S 01)
DOI: 10.1055/s-0039-1678230

Posterbegehung (P18) – Sektion Klinische Pneumologie

Klinische Studien bei COPD, Asthma, Palliativmedizin & more

Georg Thieme Verlag KG Stuttgart · New York

M Scuri

¹Gcd, Chiesi Farmaceutici

,

D Singh

²Univ Hosp of South Manchester

,

LM Fabbri

³Internal and Respiratory Medicine, Univ of Ferrara

,

A Guasconi

¹Gcd, Chiesi Farmaceutici

,

S Vezzoli

¹Gcd, Chiesi Farmaceutici

,

H Prunier

¹Gcd, Chiesi Farmaceutici

,

A Muraro

⁴Chiesi Farmaceutici S. P. A.

,

S Petruzzelli

⁴Chiesi Farmaceutici S. P. A.

,

A Papi

⁵Research Centre on Asthma and Copd, University of Ferrara